134 related articles for article (PubMed ID: 38579615)
1. Identification of benzo[b]thiophene-1,1-dioxide derivatives as novel PHGDH covalent inhibitors.
Cao XY; Li X; Wang F; Duan Y; Wu X; Lin GQ; Geng M; Huang M; Tian P; Tang S; Gao D
Bioorg Chem; 2024 May; 146():107330. PubMed ID: 38579615
[TBL] [Abstract][Full Text] [Related]
2. Discovery of PHGDH inhibitors by virtual screening and preliminary structure-activity relationship study.
Zhang FM; Yuan L; Shi XW; Feng KR; Lan X; Huang C; Lin GQ; Tian P; Huang M; Tang S; Gao D
Bioorg Chem; 2022 Apr; 121():105705. PubMed ID: 35235889
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Novel Drug-like PHGDH Inhibitors to Disrupt Serine Biosynthesis for Cancer Therapy.
Gao D; Tang S; Cen Y; Yuan L; Lan X; Li QH; Lin GQ; Huang M; Tian P
J Med Chem; 2023 Jan; 66(1):285-305. PubMed ID: 36594670
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel inhibitors of human phosphoglycerate dehydrogenase by activity-directed combinatorial chemical synthesis strategy.
Zhou X; Tan Y; Gou K; Tao L; Luo Y; Zhou Y; Zuo Z; Sun Q; Luo Y; Zhao Y
Bioorg Chem; 2021 Oct; 115():105159. PubMed ID: 34298241
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of 3-phosphoglycerate dehydrogenase (PHGDH) by indole amides abrogates de novo serine synthesis in cancer cells.
Mullarky E; Xu J; Robin AD; Huggins DJ; Jennings A; Noguchi N; Olland A; Lakshminarasimhan D; Miller M; Tomita D; Michino M; Su T; Zhang G; Stamford AW; Meinke PT; Kargman S; Cantley LC
Bioorg Med Chem Lett; 2019 Sep; 29(17):2503-2510. PubMed ID: 31327531
[TBL] [Abstract][Full Text] [Related]
6. Ixocarpalactone A from dietary tomatillo inhibits pancreatic cancer growth by targeting PHGDH.
Zheng M; Guo J; Xu J; Yang K; Tang R; Gu X; Li H; Chen L
Food Funct; 2019 Jun; 10(6):3386-3395. PubMed ID: 31112178
[TBL] [Abstract][Full Text] [Related]
7. Azacoccone E inhibits cancer cell growth by targeting 3-phosphoglycerate dehydrogenase.
Guo J; Gu X; Zheng M; Zhang Y; Chen L; Li H
Bioorg Chem; 2019 Jun; 87():16-22. PubMed ID: 30852233
[TBL] [Abstract][Full Text] [Related]
8. A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate.
Pacold ME; Brimacombe KR; Chan SH; Rohde JM; Lewis CA; Swier LJ; Possemato R; Chen WW; Sullivan LB; Fiske BP; Cho S; Freinkman E; Birsoy K; Abu-Remaileh M; Shaul YD; Liu CM; Zhou M; Koh MJ; Chung H; Davidson SM; Luengo A; Wang AQ; Xu X; Yasgar A; Liu L; Rai G; Westover KD; Vander Heiden MG; Shen M; Gray NS; Boxer MB; Sabatini DM
Nat Chem Biol; 2016 Jun; 12(6):452-8. PubMed ID: 27110680
[TBL] [Abstract][Full Text] [Related]
9. Rational Design of Selective Allosteric Inhibitors of PHGDH and Serine Synthesis with Anti-tumor Activity.
Wang Q; Liberti MV; Liu P; Deng X; Liu Y; Locasale JW; Lai L
Cell Chem Biol; 2017 Jan; 24(1):55-65. PubMed ID: 28042046
[TBL] [Abstract][Full Text] [Related]
10. Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers.
Mullarky E; Lucki NC; Beheshti Zavareh R; Anglin JL; Gomes AP; Nicolay BN; Wong JC; Christen S; Takahashi H; Singh PK; Blenis J; Warren JD; Fendt SM; Asara JM; DeNicola GM; Lyssiotis CA; Lairson LL; Cantley LC
Proc Natl Acad Sci U S A; 2016 Feb; 113(7):1778-83. PubMed ID: 26831078
[TBL] [Abstract][Full Text] [Related]
11. A retrospective overview of PHGDH and its inhibitors for regulating cancer metabolism.
Zhao JY; Feng KR; Wang F; Zhang JW; Cheng JF; Lin GQ; Gao D; Tian P
Eur J Med Chem; 2021 May; 217():113379. PubMed ID: 33756126
[TBL] [Abstract][Full Text] [Related]
12. Discovery and optimization of piperazine-1-thiourea-based human phosphoglycerate dehydrogenase inhibitors.
Rohde JM; Brimacombe KR; Liu L; Pacold ME; Yasgar A; Cheff DM; Lee TD; Rai G; Baljinnyam B; Li Z; Simeonov A; Hall MD; Shen M; Sabatini DM; Boxer MB
Bioorg Med Chem; 2018 May; 26(8):1727-1739. PubMed ID: 29555419
[TBL] [Abstract][Full Text] [Related]
13. Identification of Novel Natural Inhibitors to Human 3-Phosphoglycerate Dehydrogenase (PHGDH) for Cancer Treatment.
Sadiqa A; Rasul A; Hassan M; Sultana S; Jabeen F
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144843
[TBL] [Abstract][Full Text] [Related]
14. The Role of D-3-Phosphoglycerate Dehydrogenase in Cancer.
Zhao X; Fu J; Du J; Xu W
Int J Biol Sci; 2020; 16(9):1495-1506. PubMed ID: 32226297
[TBL] [Abstract][Full Text] [Related]
15. Homoharringtonine as a PHGDH inhibitor: Unraveling metabolic dependencies and developing a potent therapeutic strategy for high-risk neuroblastoma.
Hsieh CH; Huang CT; Cheng YS; Hsu CH; Hsu WM; Chung YH; Liu YL; Yang TS; Chien CY; Lee YH; Huang HC; Juan HF
Biomed Pharmacother; 2023 Oct; 166():115429. PubMed ID: 37673018
[TBL] [Abstract][Full Text] [Related]
16. Biophysical and biochemical properties of PHGDH revealed by studies on PHGDH inhibitors.
Tan Y; Zhou X; Gong Y; Gou K; Luo Y; Jia D; Dai L; Zhao Y; Sun Q
Cell Mol Life Sci; 2021 Dec; 79(1):27. PubMed ID: 34971423
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting phosphoglycerate dehydrogenase counteracts chemotherapeutic efficacy against MYCN-amplified neuroblastoma.
Arlt B; Zasada C; Baum K; Wuenschel J; Mastrobuoni G; Lodrini M; Astrahantseff K; Winkler A; Schulte JH; Finkler S; Forbes M; Hundsdoerfer P; Guergen D; Hoffmann J; Wolf J; Eggert A; Kempa S; Deubzer HE
Int J Cancer; 2021 Mar; 148(5):1219-1232. PubMed ID: 33284994
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel PHGDH covalent inhibitor by chemical proteomics and phenotypic profiling.
Chen C; Zhu T; Liu X; Zhu D; Zhang Y; Wu S; Han C; Zhang H; Luo J; Kong L
Acta Pharm Sin B; 2022 Jan; 12(1):246-261. PubMed ID: 35127383
[TBL] [Abstract][Full Text] [Related]
19. Intracellular Trapping of the Selective Phosphoglycerate Dehydrogenase (PHGDH) Inhibitor
Weinstabl H; Treu M; Rinnenthal J; Zahn SK; Ettmayer P; Bader G; Dahmann G; Kessler D; Rumpel K; Mischerikow N; Savarese F; Gerstberger T; Mayer M; Zoephel A; Schnitzer R; Sommergruber W; Martinelli P; Arnhof H; Peric-Simov B; Hofbauer KS; Garavel G; Scherbantin Y; Mitzner S; Fett TN; Scholz G; Bruchhaus J; Burkard M; Kousek R; Ciftci T; Sharps B; Schrenk A; Harrer C; Haering D; Wolkerstorfer B; Zhang X; Lv X; Du A; Li D; Li Y; Quant J; Pearson M; McConnell DB
J Med Chem; 2019 Sep; 62(17):7976-7997. PubMed ID: 31365252
[TBL] [Abstract][Full Text] [Related]
20. Phosphoglycerate dehydrogenase promotes pancreatic cancer development by interacting with eIF4A1 and eIF4E.
Ma X; Li B; Liu J; Fu Y; Luo Y
J Exp Clin Cancer Res; 2019 Feb; 38(1):66. PubMed ID: 30744688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
